3.0, more severe damage results in a higher serum AST/ ALT ratio.
Mitochondrial Aspartate Aminotransferase Determined by "Fast Protein Liquid Chromatography"
Marianne Grostad,1 Robert ReJ,2and Nile Erik Huseby'
We describe an improved separation of the isoenzymes of aspartate aminotransferase (EC 2.6.1.1), based on ionexchange chromatography. Involving the "Fast Protein Liquid Chromatography" system (Pharmacia) with a MonoQ column, this rapid, reproducible method for quantifying the mitochondnal enzyme shows good resolution and sensitivity, and results correlate well with those by an established immunochemical method.
The mammalian aspartate aminotransferase (A5pAT, EC 2.6.1.1) enzyme exists in two isoenzymic forms, mitochondrial (mAspAT) and cytosolic (cAspAT). Measurements of mAspAT may have diagnostic utility (1) (2) (3) (4) (5) (6) , but such determinations are not in routine use, in part because of inconvenient assay techniques and the lack of commercially available reagents.
The most nearly accurate and most sensitive assays are based on immunochemical techniques (6-9).Other procedures such as ion-exchange chromatography (2,10), electrophoresis (11), and differential kinetics (12) have also been described, and their relative merits have been compared (13 ficiently sensitive for application to sera with normal or slightly increased mAspAT activity. Teranishi et al. (15) described a technique involving protease sensitivity, but this method apparently is highly imprecise near the normal reference interval.
Here we describe an improved separation of the isoenzymes based on the ion-exchange technique described by Sampson et al. (10) and later modified by Rabkin and Desjardins (2).We have made use of the high-performance separation of monodispersed particles ("Monobeads") and the "Fast Protein Liquid Chromatography" (FPLc) system to attain fast, reproducible separation with high recovery. Moreover, separation and quantification of the isoenzymes with this technique is independent of the species specificity of antibodies; thus the technique potentially is applicable to both human and animal studies.
Materials and Methods

Chromatographic separations.
We used the standard FPLC system (Pharmacia, LKB Biotechnology, Uppsala, Sweden) with a 5 x 50 mm colunm of MonoQ HR 5/5 ion-exchange resin. The column was equilibrated with buffer A: per liter, 50 mmol of Tris hydrochloride (pH 8.1 at 25 #{176}C) and 50 mmol of NaC1. All samples were diluted threefold with buffer A, passed through a 0.22-pm (pore size) filter (Millex-GS; Millipore, Molsheim, France), and 0.5 mL of filtrate was applied to the column. The column was eluted with 3 mL of buffer A and then with a linear gradient (0-100%) of buffer B (per liter, 50 mmol of the Tris hydrochloride buffer and 300 mmol of NaC1) in 7 mL. The Purified mAspAT and cAspAT were added to a solution of albumin to give concentrations indicatedby 'Known value," and mAspAT was measured repeatedly.
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Column maintenance.
Routinely,
we washed the column with 1 mL of 1 mol/L NaOH followed by 1 mL of 2 mol/L NaCI after each six runs, using reversed flow. The prefilter on the column was changed after each 18 runs. This maintained the column pressure at 0.5 to 1.5 MPa.
A higher flow rate than 0.5 mL/min may be used, but owing to the large amount of protein applied to the column, both the column and the preffiter are easily clogged, resulting in increased pressure.
Sample preparations.
Human myocardium was obtained at autopsy (within 20 h after death) and homogenized in 0.1 mol/L Tris hydrochloride (pH 8.0). Partly purified preparations of the two isoenzymes were obtained after precipitation with ammonium sulfate, followed by chromatography on DEAE A50 Sephadex and CM-Sephadex C-50 (Pharmacia), as described elsewhere (10) . Mixtures of the isoenzymes were prepared in a matrix of, per liter, 30 g of human albumin, 0.1 mol of Tris hydrochloride (pH 7.5 at 25#{176}C), 0.1 mol of NaCl, and 50 pmol of pyridoxal phosphate, in concentrations described below in Results. Serum was sampled from hospitalized patients with myocardial infarctions.
Enzyme activity measurements.
Enzyme activity was measured in an "Ultrospec K" spectrophotometer (Pharmacia LKB Biotechnology) at 37 #{176}C, according to the recom- For measuring AspAT activity in column eluates, we reconstituted the Boehringer kit reagent with #{188} of the recommended volume. A volume of 0.25 roL of this mixture was pre-incubated at 37#{176}C with the 0.90-mL eluent volume for 10 mm, and the reaction was monitored photometrically for 1.5 mm after 0.10 mL of a 150 mmol/L solution of 2-oxoglutarate was added. The assay conditions with respect to substrate/co-substrate concentrations were the same as forthe determinationoftotal AspAT. The final pH values changed slightly (<0.1 unit), owing to the large volume fraction of specimen, with no apparent effect on the accuracy of the determination.
We calculated the mAspAT composition in serum (or other samples) after summing the activity of the two eluate fractions representing unbound (mAspAT) activity (fractions 2 and 3) and multiplying this activity by the factor 5.4. This conversion factor [5.4 = 3 x (1/0.5 mL) x 0.9 mU is calculated from the dilution factor (1:3), the volume (0.5 mL) of sample applied, and the volume of each fraction (0.9 mL). The reagent blank reaction, equivalent to <2 UIL, was estimated for each series and deducted from each sample analyzed.
mAspAT was immunoassayed as previously described 
12
Eluate volume(mL) Fig. 1 . Elution profile of AspAT isoenzymes after chromatography on the MonoQ column Thesample wasserum from a patient with rnyocardialinfarction.Total A8pAT activity was 98 U/L;mAspAT activity was 14 U/L. Recovery of total AspAT activitywas98% samples of partly purified mAspAT and cAspAT added to an albumin matrix.
The coefficient of variation was <4.5% for three concentrations of mAspAT in the solution of albumin. CVs were similar for repeated analyses of serum samples with abovenormal mAspAT (Table 2 ) but were significantly higher for normal serum.
Analytical recovery for both isoenzymes ranged between 90% and 108%. Recovery was similar for total AspAT activity, as assessed by analysis of more than 50 serum samples.
To test the binding capacity of the column for cAspAT, and thus the possible positive bias of cAspAT on the mAspAT determination, we added increasing amounts of cAspAT to the albumin solution and assayed. Activities up to 1000 U/L did not result in significant increases in the activity of the unbound fractions, nor was binding of cAspAT to the column altered by changing the pH of the buffer to 7.8 or to 8.5. Table 2 alsoshows a comparison of the present method with the immunological method for replicate assays of pooled human serum. The two procedures produced identical mean values for mAspAT both in serum with increased activity and in serum with normal activity. Figure 2 shows a comparison of the two assays when used to measure mAspAT in 34 different serum samples with total A5pAT activity ranging from 32 to 550 UIL.
Discussion
We found that using the standard FPLC system provides reproducible, sensitive quantification of AspAT isoenzymes. The resolution of the two isoenzymes was good, even for cAspAT activities near 1000 UIL. However, if the washing procedure of the column was neglected, the cAspAT peak broadened, with resulting overlap of the isoenzyme peaks. Loading the column with the specified amounts of serum may lead to clogging of both the column and the prefilter after 10 to 12 runs, with a resulting increase in pressure and possible destruction of the column, so we routinely wash the column after every six runs. For these same reasons, we run the column at a flow rate of 0.5 mU/mm. However, the separation is not affected by flow rates up to 1 mU/mm, which of course would shorten the separation time.
The method is satisfactorily reproducible. As shown in Tables 1 and 2 , the CVs were <4.5%, even when mAspAT activity was slightly increased. Although the CV was significantly increased for activities at the upper normal reference values-reportedly <4 U/L at 30#{176}C (6), which corresponds to <5 UIL at 37#{176}C-the method appears to be sufficiently sensitive for determining mAspAT in sera with normal or slightly above-normal activities.
The reagent blank reaction, estimated in fractions containing no enzyme activity, was equivalent to <1-2 UIL, similar to other reported methods (7, 10) . These low variations in blank values make the method sensitive and reliable in the low-activity range, as is further substanti- There is a slight negative bias of the chromatographic procedure when compared with the immunological technique over the entire analytical range (Figure 3 ), but this bias is significantly less than that reported for comparison of the immunological method and the original ion-exchange technique (13) . In the critical normal to slightly above-normal range of mAspAT activity, this bias is insignificant (<1 UIL).
The present technique is a reliable alternative as a non-immunological assay. Studies on the application of the method to human medicine and veterinary experimental studies are in progress.
